What happened
Continue Reading Below
Consumer-staples giant Colgate Palmolive (NYSE: CL) gained 15% last year to modestly trail the broader market and its 19% rise, according to data provided by S&P Global Market Intelligence.
Reflecting its stable business, Colgate’s stock showed little volatility during the year as it oscillated between gains of between 17% and 8%. Its final 15% increase, while underperforming the market, put it ahead of rivals, including Procter & Gamble and Kimberly Clark.
So what
Colgate’s 2017 was characterized by solid operating performance in a weakening market. Organic sales growth slowed during the year, which led management to back away from their original target of between 4% and 7% sales gains. “Uncertainty in global markets and category growth worldwide remain challenging,” CEO Ian Cook told investors in late April, and he echoed those comments in each of the company’s next two quarterly reports.
On the bright side, Colgate continued to dominate its industry niches, with market share sitting at 44% of the global toothpaste market as of late October. Gross profit margin stayed strong, at over 60% of sales, to deliver plenty of support for its healthy dividend.
Continue Reading Below
ADVERTISEMENT
Now what
Investors have a few reasons to expect an uptick in organic growth over the coming quarters. First, economic growth has sped up in many key markets. Second, Colgate has increased its advertising spending, which helped sales gains rise to a 1.5% pace in the third quarter from 0% in the prior quarter. The company is hoping to build on that early momentum with an even better growth result when it announces fourth-quarter results on Jan. 26.
10 stocks we like better than Colgate-Palmolive
When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has tripled the market.*
David and Tom just revealed what they believe are the 10 best stocks for investors to buy right now… and Colgate-Palmolive wasn’t one of them! That’s right — they think these 10 stocks are even better buys.
Click here to learn about these picks!
*Stock Advisor returns as of January 2, 2018
Demitrios Kalogeropoulos has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.
